title: 2015 new drug update.
abstract: Six new drugs approved within the last two years, which are used for medical problems often experienced by the elderly, have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author. Advantages, disadvantages, and other important information regarding the new drug are identified and used as the basis for determining the rating. The drugs include two antidiabetic agents, one bronchodilator, one antidepressant, one for erectile dysfunction, and one for menopause-associated conditions.
authors.affiliation: Philadelphia College of Pharmacy at the University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
mesh_terms: D001559:Benzhydryl Compounds / Q000627:therapeutic use; D017277:Drug Approval; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives / Q000627:therapeutic use; D005960:Glucosides / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000008:administration & dosage; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011812:Quinuclidines / Q000627:therapeutic use; D013440:Sulfides / Q000627:therapeutic use; D000078784:Vortioxetine
chemical_list: D001559:Benzhydryl Compounds; D004966:Estrogens, Conjugated (USP); C573971:GSK573719; D005960:Glucosides; D007211:Indoles; D010879:Piperazines; D011743:Pyrimidines; D011812:Quinuclidines; D013440:Sulfides; D000078784:Vortioxetine; C534611:rGLP-1 protein; D052216:Glucagon-Like Peptide 1; C553414:avanafil; C570240:empagliflozin; C447119:bazedoxifene